Resistance to the Tyrosine Kinase Inhibitor Osimertinib and Pharmacokinetics in Non-small Cell Lung Cancer
Clinical trial NCT05020275 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05020275
- Sponsor
- Rennes University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-29
- Primary completion
- 2026-03-16
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.